Evidence map›Paper›PMID 39669245›Full record

ArticleGenetics in medicine open2023

Systematic gene-disease relationship (GDR) curation unveils 61 gene-disease associations and highlights the impact on genetic testing.

Emir Zonic, Mariana Ferreira, Luba M Pardo, Javier Martini, Maria Eugenia Rocha, Ruxandra Aanicai, Natalia Ordonez-Herrera, Deepa Saravanakumar, Ligia S Almeida, Inês C Fernandes and 10 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Journal of medical genetics · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Emir ZonicCENTOGENE GmbH, Rostock, Germany.
Mariana FerreiraCENTOGENE GmbH, Rostock, Germany.
Luba M PardoCENTOGENE GmbH, Rostock, Germany.
Javier MartiniCENTOGENE GmbH, Rostock, Germany.
Maria Eugenia RochaCENTOGENE GmbH, Rostock, Germany.
Ruxandra AanicaiCENTOGENE GmbH, Rostock, Germany.
Natalia Ordonez-HerreraCENTOGENE GmbH, Rostock, Germany.
Deepa SaravanakumarCENTOGENE GmbH, Rostock, Germany.
Ligia S AlmeidaCENTOGENE GmbH, Rostock, Germany.
Inês C FernandesCENTOGENE GmbH, Rostock, Germany.
Nishtha GulatiCENTOGENE GmbH, Rostock, Germany.
Sumanth MannepalliCENTOGENE GmbH, Rostock, Germany.
Amela HercegovacUniversity of Tuzla, Faculty of Natural Sciences and Mathematics, Bosnia and Herzegovina.
Ruslan Al-AliCENTOGENE GmbH, Rostock, Germany.
Catarina PereiraCENTOGENE GmbH, Rostock, Germany.
Omid PakniaCENTOGENE GmbH, Rostock, Germany.
Uros HladnikCENTOGENE GmbH, Rostock, Germany.
Peter BauerCENTOGENE GmbH, Rostock, Germany.
Jorge Pinto BastoCENTOGENE GmbH, Rostock, Germany.
Aida M Bertoli-AvellaCENTOGENE GmbH, Rostock, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: With this study, we aimed to explore the gene-disease relationship (GDR) evidence for 109 gene-disease pairs and the significance of a large Biodatabank for this classification. Methods: The Clinical Genome Resource (ClinGen) Clinical Validity Framework for evaluation of GDR was applied. Most of the assessed genes were without a phenotype entry in the Online Mendelian Inheritance in Man (OMIM) database. Our Biodatabank with genetic data from over 670,000 previously tested individuals, in addition to data available in literature and public databases, were used for gene curation. Results: We confirmed 61 GDR (Definitive: 4 genes, Strong: 22 genes, Moderate: 35 genes). For 84 of 109 gene-disease pairs, a higher score was reached when using data from our Biodatabank in addition to externally obtainable data. This increased the final level of classification in 21 of the genes. Over 400 patients received a genetic report with clinically relevant variants in these 61 genes. Conclusion: Our results demonstrate the importance of careful assessment of gene clinical validity data, along with the use of genetic data repositories. Implementation of the ClinGen Clinical Validity Framework for assessment of GDR is relatively straightforward. We encourage diagnostic laboratories to implement such a system and contribute to closing the knowledge gap in genetic research and diagnostics.

Indexed as

Gene classificationGene curationGene-disease associationGene-disease relationshipGene-validity

Identifiers

PMID39669245
PMCPMC11613557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.